This inventor holds 4 USPTO granted patents. Top assignee: Asta Medica, Aktiengesellschaft. Active years: 1996-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-2000
Title: Innovator Gabriela Pergande: Pioneering Advances in Medical Therapy
Introduction
Gabriela Pergande, an accomplished inventor based in Offenbach, Germany, has made significant contributions to the field of medical therapy. With a total of 4 patents to her name, she has focused her research on the therapeutic use of flupirtine, particularly in relation to diseases that impair the haematopoetic cell system, such as HIV/AIDS.
Latest Patents
Among her latest patents, the invention titled "Use of flupirtine for the prophylaxis and therapy of diseases associated" stands out prominently. This patent details the application of flupirtine or its salts as drugs in the prevention and treatment of conditions related to the impairment of lymphocytes. This innovative approach is especially crucial for the treatment of HIV-infected patients and those suffering from AIDS. By addressing such urgent medical needs, Pergande's work holds the potential to improve patient outcomes and enhance the quality of life for many.
Career Highlights
Gabriela Pergande's career at Asta Medica Aktiengesellschaft has been marked by a strong commitment to research and development in the pharmaceutical sector. Her innovative mind has driven her to explore and implement novel therapeutic strategies, gaining recognition in both academic and medical circles. Her relentless pursuit of knowledge and problem-solving ability has made her a key figure in her field.
Collaborations
Throughout her career, Pergande has collaborated with notable professionals, including Bernd Nickel and Jurgen Engel. These collaborations have undoubtedly contributed to the depth and breadth of her research, allowing her to leverage diverse expertise and enhance the impact of her inventions.
Conclusion
In summary, Gabriela Pergande is a remarkable inventor whose work in the application of flupirtine for medical therapy has the potential to transform treatment approaches for diseases associated with the haematopoetic cell system. With her impressive patent portfolio and collaborative spirit, she continues to pave the way for innovative solutions in the biomedical field, making a meaningful difference in the lives of countless patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile